Takeki Okumoto

1.4k citations
38 papers · 1.2k indexed · h-index 15
Topics
Inflammatory mediators and NSAID effects (7 papers)Microbial Natural Products and Biosynthesis (5 papers)Cancer therapeutics and mechanisms (4 papers)
Partner nations
JapanUnited States

In The Last Decade

Takeki Okumoto

38 papers receiving 1.1k citations

Peers

Takeki Okumoto
Comparison fields: 5 of 92
  • Molecular Biology 726
  • Organic Chemistry 299
  • Pharmacology 217
  • Immunology 147
  • Cell Biology 94
Replace Shigeo Sasaki with:
Shigeo Sasaki Japan
France Laliberté Canada
Hans‐Ulrich Demuth Germany
W S Sly United States
Marina Mojena Spain
Akinori Arimura Japan
John P. Alao Sweden
Ke‐He Ruan United States
John T. Dulaney United States
Rosemary Thornton United States
Takeki Okumoto relative to Shigeo Sasaki Japan Shigeo Sasaki's profile →
Citations per field
00.5×1.6×
Shigeo Sasaki · 1×
Citations per year

Countries citing papers authored by Takeki Okumoto

Since Specialization
Citations

This map shows the geographic impact of Takeki Okumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeki Okumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeki Okumoto more than expected).

Fields of papers citing papers by Takeki Okumoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeki Okumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeki Okumoto. The network helps show where Takeki Okumoto may publish in the future.

Co-authorship network of co-authors of Takeki Okumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Takeki Okumoto. A scholar is included among the top collaborators of Takeki Okumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeki Okumoto. Takeki Okumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 92
3 62
4 9
5 9
6 55
7 10
8 15
9 9
10 12
11 1
12 72
13 28
14 23
15
A Novel Immunosuppressant, ISP-I, of Isaria sinclairii
2
16 14
17 1
18
Enhancement of host defence by Y-19995 (2,4'-bis(1-methyl-2-dimethyl-aminoethoxyl)-3-benzoylpyridine dimaleate), a novel synthetic compound. I. Accelerated restoration from the leukocytopenia and augmented protection against microbial infections in immunocompromised mice.
1
19 5
20 7

About Takeki Okumoto

Takeki Okumoto is a scholar working on Toxicology, Pharmacology and Immunology and Allergy, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Microbial Natural Products and Biosynthesis (5 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Pharmacology (217 citations), Molecular Biology (726 citations) and Organic Chemistry (299 citations). Takeki Okumoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Kenji Chiba, Yukio Hoshino, T. Ikumoto, Tetsuro Fujita, Ken‐ichiro Inoue, Shigeo Sasaki, Satoshi Yamamoto, Mamoru Matsuura, Hirofumi Matsuyuki and Hidenobu Kusuhara. Their work appears in journals such as Nucleic Acids Research, Biochemical Pharmacology and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026